Jeff has been a Partner at Plymouth Growth since 2008 and is involved in all aspects of the firm’s investing activities, from origination to exit. He has led several successful investments in Funds II, III & IV including IDV Solutions, 365 Retail Markets, Kinney Group and Allied Payment Network. Jeff is an experienced finance professional and brings over 20 years of experience to collaborating with Plymouth’s portfolio companies.

Prior to joining Plymouth, Jeff was a Senior Economist at the Overseas Private Investment Corporation (OPIC) in Washington, DC where he was responsible for evaluating potential investment opportunities in small- and medium-sized businesses, as well as Fortune 500 companies. Prior to his work with OPIC, Jeff was a management and strategy consultant for ten years with PricewaterhouseCoopers and Stone & Webster Management Consultants, specializing in sell-side privatization transactions in Latin America and Africa.

Jeff holds an MBA in Finance from Vanderbilt University and a Bachelor of the Arts from Trinity College in Economics and Spanish, with other graduate studies at New York University and Georgetown University.

Ann Arbor, Traverse City and metro Detroit area businessman Chet Czaplicka is a graduate of Wayne State University and the Harper Hospital School of Perfusion Technology. He is a registered nurse in both Michigan and Indiana, where he pursued a Master of Science degree in administration from the University of Notre Dame.

Chet currently serves as CEO of Comprehensive Care Services, one of the nation’s leaders in perfusion and autotranfusion services. Comprehensive Care Services is certified by the Joint Commission and provides superior perfusion and autotransfusion services. CCS Perioperative Blood Management Technologists (PBMT) are certified by the International Board of Blood Management. Chet is well known in Michigan as a successful entrepreneur. He is also co-owner of Grizzly Peak Brewing Company, Vinology wine bar, and The Blue Tractor in Ann Arbor, and North Peak Brewing Company in Traverse City.

Chet brings with him 25 years of hands on experience ranging from clinical perfusion and employee training to strategic planning and budgeting in a variety of professional settings.

Patty Fanelli is the Senior Vice President and co-owner of Comprehensive Care Services. Patty is a Board Certified Clinical Perfusionist and has been working in Cardiac Surgery for over 30 years. She has a strong background in Joint Commission guidelines, CAP, CLIA and Federal regulations. She developed policies and procedures, education competencies, regulatory guidelines and training manuals currently used today in the field of Regenerative Medicine.

She was involved in the development of the “Medtronic StemPrep Kit” for BMAC use currently owned by Arteriocyte and has been a national speaker for Biologics since 2006 training hundreds of perfusionists and physicians in the world of Regenerative Medicine.

She also has strategic relationships with all National vendors, perfusion organizations and many Clinical Advisory Boards and trial sites allowing for the future growth of 3T Medical Complete. Patty has her degree in Medical Technology and her postgraduate degree in Perfusion Technology.

Dr. Jack Kelley is Chief Executive Officer and Board Member of 3T Medical Complete Systems. Dr. Kelley has over 19 years of broad leadership experience in medical device and pharmaceutical drug delivery. Dr. Kelley has experience across a number of growth businesses and sectors key to healthcare commercialization and innovation, including, small and large cap medical device and pharmaceutical drug delivery corporations, venture capital, investment banking, and life science research.

Dr. Kelley has worked at Medtronic, JP Morgan and Becton Dickinson. Prior to 3T Medical Complete Systems, he served as a Vice President of Unilife, an innovative drug delivery company with a proprietary prefillable syringe with retractable needle technology. Prior to Unilife, he served as the Worldwide Director, Strategic Marketing and Business Development at BD Pharmaceutical Systems, a leading supplier of conventional prefilled syringes. Dr. Kelley also served as Worldwide Director, Research and Development for BD Medical Surgical Systems, a leading supplier of acute care consumables. Prior to BD, Dr. Kelley was Manager, Ventures and Business Development for Medtronic Diabetes, a market and technology leader in insulin drug delivery, where he was responsible for the general medication infusion pump business development activities with pharmaceutical and biotechnology companies.

Prior to his industrial career, Dr. Kelley held a dual faculty appointment as a Research Assistant Professor at Dartmouth College in the Departments of Chemistry and Computer Science. Dr. Kelley has published patents and multiple peer reviewed journal articles on the biophysical characterization of proteins and DNA in solution. He holds a Doctorate in Biophysical Chemistry from Dartmouth College, an MBA from the University of Michigan, and a Bachelor’s degree in Chemistry from Marquette University.

Ian is Plymouth’s founding partner and has been active in venture capital investing since 1969. He brings extensive financial, operational and technological expertise to Plymouth Growth Partners.

Ian formed the first institutional VC in Michigan and has led or co-led 14 funds. He has been involved in building over 350 companies, executing over 40 IPOs, and serving on the Board of more than 20 businesses. Successful exits include numerous strategic sales, such as Ventana Medical Systems, Lifescan, Birtcher, Stratacom, and Neogen.

Ian received an MBA from Harvard University and a Bachelor of Economics from the University of Sydney. He is an Australian Chartered Accountant.